Road to Victories

Rob Vogelaar Patient Family

Born and raised in Holland, Rob has lived in the States both on the East and West coast since ’98. Having a twin and younger brother in his native Holland Rob is close with his two USA brothers Pat and Tim Nash. Tim is a multiple myeloma patient and is currently in remission. In early 2020 Rob got the road cycling ‘bug’ and one year of steady training later decided to join Tim and Pat for the event in Oregon. Rob is very proud to be riding for the MMRF. As a Dutchman cycling is special and to be able to do it with his brothers while celebrating life in the beautiful USA will be the experience of a lifetime.

Sorry, there are no posts from this member.

The mission of the Multiple Myeloma Research Foundation (MMRF) is to find a cure for multiple myeloma by relentlessly pursuing innovation that accelerates the development of next-generation treatments to extend the lives of patients. Founded in 1998 by Kathy Giusti, a multiple myeloma patient, and her twin sister Karen Andrews as a 501(c) (3) nonprofit organization, the MMRF is a world-recognized leader in cancer research. Together with its partners, the MMRF has created the only end-to-end solution in precision medicine and the single largest genomic dataset in all cancers. The MMRF continues to disrupt the industry today, as a pioneer and leader at the helm of new research efforts. Since its inception, the organization has raised over $400 million and directs nearly 90% of the total funds to research and related programs. Learn more and sign up to receive news and resources from the MMRF.

Learn More

Sponsored by

At Janssen Oncology, we’re shaping the future of cancer treatment. In the process, we’re striving to change expectations of what a cancer diagnosis means. Our purpose is driven by an urgency and commitment to bringing transformational cancer solutions to the people who need them. Passionate about our work, we are driven by the personal connection many of us share with the disease. With our partners, we focus on delivering solutions that make a positive impact on human health. We are part of Janssen Biotech, Inc., and the Janssen Pharmaceutical Companies of Johnson & Johnson.

About Janssen Oncology

Click below to learn more about a treatment option for multiple myeloma. If you’re also interested in getting more information from Janssen, sign up for ongoing communications.

Learn More